Van Bael & Bellis leverages its competition and life sciences sector knowhow to represent major cross-border clients in high-stakes mandates. Drawing upon a wealth of experience within regulated sectors and the life sciences space, practice head Catherine Longeval is an expert in Enterprise Court proceedings and CEPANI arbitration. Complementing his expertise on life sciences matters, Peter L’Ecluse is also particularly sought-after for his track-record in IP and competition-focused litigation. Koen T’Syen brings a particular focus on commercial dispute resolution, representing clients in contract, distribution, and competition proceedings.
\nLegal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team is very lean, but always reacting very fast and professionally.’
- ‘Catherine Longeval is always very efficient and detailed in her support.’
- ‘The team is lean and mean, excellent responsiveness and very much an eye for detail, on the facts and the law.’
- ‘Catherine Longeval has great strategic skills and shows much authority in the court room.'
- 'Vincent Reijns is very elaborate where needed, but at the same time concise where appropriate. Always available.’
Key clients
- ABO Infinium Americas Opco
- Allianz
- Amphenol
- AstraZeneca
- Bidfood
- Cavagna Group
- Coca-Cola Euro-Pacific Partners
- Elicio
- GlaxoSmithKline Biologicals
- Malysse
- Robert Bosch
- Scholt Energy
Work highlights
Represented DSM Nutritional Products NV in a product liability dispute involving various jurisdictions and parties.
Representing Dr. Willmar Schwabe & Co. KG in cease-and-desist proceedings against parallel trader Orifarm in relation to one of Schwabe’s medicinal products.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Catherine Longeval
Other key lawyers
Peter L'Ecluse; Koen T'Syen; Vincent Reijns